GlaxoSmithKline

Big Pharma-funded paper recommends taxing the unvaccinated

Kit Knightly A new paper published by Oxford University’s Center for Business Taxation discusses – and in the end supports – the idea of a special tax levied on those who decline to be “vaccinated” against “Covid19”. The paper’s authors argue that a vaccine-related tax would be “justified” because “Taxes on behaviour that is considered …

The Antibody Deception

Rosemary Frei, MSc via her website The world has been fixated for months on novel-coronavirus PCR testing, contact tracing and vaccination. Meanwhile, another major part of the Covid biomedical complex has received far less attention: the use of antibodies for detecting, diagnosing and treating infection with the novel coronavirus. Hundreds of antibodies have been approved …

COVID-19: RDIF Points to Absence of Long-Term Studies on Vaccines Based on Monkey Adenoviral Vectors

By Aleksandra Serebriakova – Sputnik – 09.09.2020

The third round of trials for the AstraZeneca anti-COVID-19 drug is now on pause over “potentially unexplained illness” in a participant in the UK. On 11 August, Russia registered its own Sputnik V anti-coronavirus vaccine, which is said to have been developed in a different way.

Big Pharma Giants GlaxoSmithKline, Sanofi Receive $2.1 Billion to Develop COVID Vaccine

The Trump administration’s “Manhattan project” for a COVID-19 vaccine has topped its biggest award given only two weeks ago to Novavax, Inc with its latest grant of $2.1 billion to pharmaceutical giant, GlaxoSmithKline, and partner Sanofi Pasteur to “speed up clinical development and manufacturing” of its recombinant vaccine candidate for the novel coronavirus.

Déjà Vu: GSK Recycles Its Problematic Adjuvant into Covid-19 Vaccines

By the Children’s Health Defense Team Among the 100 or so global players now working on experimental Covid-19 vaccines, most of the entities touted as frontrunners are obscure biotechnology and nanotechnology firms. Despite their focus on razzle-dazzle “next-generation” technologies that private foundations, the U.S. government and the military apparently find alluring, few of these companies have any prior experience successfully bringing vaccines to market. In contrast, some […]

Pharma Companies Spend 19x more on Marketing than Research, and Returns are Dropping

The pharmaceutical industry swears the high cost of drugs is due to research and development costs, conveniently omitting the actual amount of money spent on the marketing of these drugs, which is exorbitantly more. A recent Deloitte report suggests that pharmaceutical companies are taking a hit because investments made in R&D on new drugs simply are not paying off anymore. [1]

Apple and GlaxoSmithKline Team Up for an Arthritis Study

In March of last year, Apple created the ResearchKit, a medical platform which turns the iPhone into a diagnostic tool for clinical trials and studies. It allows companies wishing to perform trials to team up easily with those wishing to participate. Recently, GlaxoSmithKline announced itself as the first ever partner for the clinical trials, as it will be conducting a study on rheumatoid arthritis.